Beryl Drugs Limited (BOM:524606)

Market Cap	92.30M
Revenue (ttm)	201.48M
Net Income (ttm)	798.00K
Shares Out	5.07M
EPS (ttm)	0.16
PE Ratio	115.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,518
Average Volume	1,236
Open	20.29
Previous Close	21.12
Day's Range	20.07 - 21.12
52-Week Range	20.07 - 46.00
Beta	0.56
RSI	28.47
Earnings Date	May 30, 2025

About Beryl Drugs

Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services. The company also exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In 2023, Beryl Drugs's revenue was 267.30 million, a decrease of -0.53% compared to the previous year's 268.71 million. Earnings were 7.69 million, an increase of 0.34%.